U.S. stock volatility: Apnimed surged on September 29 as NDA was accepted + Oxnimbi
Bitget异动解读2026/09/29 15:40Apnimed September 29th Surge Analysis
Keywords: NDA Acceptance, Oxnimbi
1. On September 8th, the company announced that the U.S. Food and Drug Administration had accepted the New Drug Application for AD109, proposed trade name Oxnimbi, and set the target review action date for February 28, 2027. The product has entered the regulatory review phase.
2. On August 25th, institutions initiated coverage on the company, assigning a “Buy” rating and a target price of $41. Data show that in its Phase III study, Oxnimbi reduced the apnea-hypopnea index by 34%–44%, targeting around 10.5 million diagnosed but untreated patients.
3. On August 3rd, the company completed an upsized initial public offering, issuing 13.8 million shares and raising a total of $220.8 million. The company is primarily engaged in the research, development, and commercialization of oral therapies for sleep-related breathing disorders, providing funding to support Oxnimbi’s potential commercialization.
(Disclaimer: This content is summarized from publicly available information using AI technology and is for reference only. It does not constitute investment advice.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
New York gold futures rose 1% intraday to $4210.10 per ounce.
The probability of a rate hike in October has dropped to 50%. The Federal Reserve's "third in command" stated: another rate hike is needed this year, but there is no need to rush.
John Williams, President of the New York Federal Reserve, stated that if the economy performs broadly in line with expectations, it may be appropriate to raise interest rates once more later this year, but the September rate hike has allowed for more observation time, and “there is no need to act in haste.” Following Williams' remarks, the market's expectation for a Federal Reserve rate hike in October fell from around 70% to about 50%.
US Stock Market Movement: Meta soars on September 29 — Enterprise AI Platform and Small Business Muse
Sector Update: Consumer Stocks Mixed Late Afternoon
Crypto prices
More
